Steven Cantor New Jersey was the founder

Steven Cantor New Jersey was the founder, Chairman of the Board, and CEO of Vasomedical, Inc., developer of an innovative heart disease device used in prestigious medical centers around the world, such as The Mayo Clinic,and The Miami Heart Institute.   Vasomedical Inc. provides superior medical products and services that address unmet clinical needs in the managementof patients with heart disease

Technological and clinical advancement led to the development of EECP -Enhanced External Counterpulsation, the therapeutic systems exclusively designed and manufactured by Vasomedical with sequential pneumatic compression to increase retrograde diastolic flow, venous return and systolic unloading, greatly improve the ease of use, patient safety and clinical effectiveness.

Steven Cantor New Jersey traveled to the Sun Yat-sen Medical University in Guangzhou, China to conduct due diligence on a non invasive device for the treatment of heart disease that subsequently received United States
Food and Drug Administration (FDA) approval and was launched worldwide and described as a major medical breakthrough in heart disease. Known as  the Enhanced External Counter Pulsation (EECP) treatment for coronary artery disease it is used worldwide in over 1,000 centers including at the Mayo Clinic, the Cleveland Clinic, Beth Israel Medical Center, Johns Hopkins,the Ochsner Foundation Hospital, The Miami Heart Institute, Scripps Center for Integrative Medicine and the Texas Heart Institute.

Steven Cantor New Jersey wanted to do more for more people and he left his day to day operational positions at the Company he founded to pursue other interests in the healthcare industry with the Former President of Merck International joining as Chairman of the Board and CEO, the positions Mr. Cantor held during his tenure.

Steven Cantor Imojo, Inc.

Steven Cantor is a successful health care entrepreneur and visionary. Steven Cantor Imojo, Inc. achievements in advancing health care by identifying and helping launch important life changing technologies are numerous. Additionally, his philanthropic deeds both financially and personally have been generous with projects including the launch of Stand Up To Cancer that has raised over $250 million since its meteoric launch in 2008.

Steven Cantor has been involved in the medical industry for over 25 years during which time Steven Cantor Imojo, Inc. has been a valuable proponent of early cancer detection efforts, as well as an advocate and supporter in favor of efforts relating to medical and cancer research. During the past twenty-five years he has have developed significant resources throughout the world to help identify, finance and advance the launch of ground-breaking life saving medical technologies, in areas of health care including Alzheimer’s disease treatment, cardiovascular disease treatment, cancer detection, screening and treatment, and substance abuse detoxification. These technologies have emanated from and are utilized at renowned centers of excellence including MD Anderson Cancer Center, Memorial Sloan-Kettering Cancer Center, Los Alamos National Laboratory, Harvard Medical School, Mayo Clinic, Cleveland Clinic, Duke University Medical Center and Wake Forest University.